MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study

OBJECTIVE: RESTORE was a randomized, partially placebo-controlled exploratory study evaluating multiple sclerosis (MS) disease activity during a 24-week interruption of natalizumab. METHODS: Eligible patients were relapse-free through the prior year on natalizumab and had no gadolinium-enhancing les...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Robert J., Cree, Bruce A.C., De Sèze, Jerome, Gold, Ralf, Hartung, Hans-Peter, Jeffery, Douglas, Kappos, Ludwig, Kaufman, Michael, Montalbán, Xavier, Weinstock-Guttman, Bianca, Anderson, Britt, Natarajan, Amy, Ticho, Barry, Duda, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011468/
https://www.ncbi.nlm.nih.gov/pubmed/24682966
http://dx.doi.org/10.1212/WNL.0000000000000355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011468/
https://www.ncbi.nlm.nih.gov/pubmed/24682966
http://dx.doi.org/10.1212/WNL.0000000000000355

Ejemplares similares